Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
NOVARTIS AG |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 86.14 CHF | +0.89% | +0.20% | +3.05% | |
| 12:35am | Blackstone explores sale of Anthos Therapeutics -sources | RE |
| Dec. 04 | Blackstone Mulling Potential Sale of Blood-Thinner Developer Anthos | MT |
Chart calendar Novartis AG
c7c4796a428f7.DHlLzhQkybKkRnug_xaTZnLipmEK6ive2gzRrm1Jm2Q.akgaq2VijtXCAkvDkC7kUz6K9wNQvkjmv0v85zcE7SVOKTOFJUqb--w-CA~57e0ad78ff62acfb91bf7663be23df26
Upcoming events on Novartis AG
Past events on Novartis AG
| 2023-11-28 08:30 am | R&D Day |
| 2023-11-14 | Wolfe Research Healthcare Conference |
| 2023-11-14 | UBS European Conference |
| 2023-11-13 | Credit Suisse Healthcare Conference |
| 2023-11-13 10:30 am | Impact and Health Equity Conference |
| 2023-11-07 | UBS BioPharma Conference |
| 2023-10-24 08:00 am | Q3 2023 Earnings Call |
| 2023-10-24 07:00 am | ESMO Congress |
| 2023-10-24 01:00 am | Q3 2023 Earnings Release |
| 2023-10-23 11:10 am | ESMO Congress |
| 2023-10-03 | Spin off |
| 2023-09-15 04:00 am | Extraordinary Shareholders Meeting |
| 2023-09-12 | Bank of America Global Healthcare Conference |
| 2023-09-11 | Morgan Stanley Global Healthcare Conference |
| 2023-09-05 | Citi BioPharma Conference |
| 2023-07-18 08:00 am | Q2 2023 Earnings Call |
| 2023-07-18 01:00 am | Q2 2023 Earnings Release |
| 2023-06-28 | Stifel European Healthcare Conference |
| 2023-06-21 | J.P. Morgan European Healthcare Conference |
| 2023-06-20 | Citi European Healthcare Conference |
Past dividends on Novartis AG
| 2023-10-03 | 0 CHF |
| 2023-03-08 | Annual 3.2 CHF |
| 2022-03-07 | Annual 3.1 CHF |
| 2021-03-03 | Annual 3 CHF |
| 2020-03-02 | Annual 2.95 CHF |
| 2019-04-08 | 0 CHF |
| 2019-03-03 | Annual 2.85 CHF |
| 2018-03-05 | Annual 2.8 CHF |
| 2017-03-01 | Annual 2.75 CHF |
| 2016-02-24 | Annual 2.7 CHF |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51 900 52 019 -0.23% | 47 445 47 897 -0.94% | 48 659 49 074 -0.85% | 51 626 51 902 -0.53% | 50 545 51 352 -1.57% | 46 223 |
|
EBITDA Million USD | Released Forecast Spread | 15 646 15 426 1.43% | 15 809 15 640 1.08% | 16 845 16 496 2.12% | 18 246 18 336 -0.49% | 18 613 17 036 9.25% | 18 118 |
|
EBIT Million USD | Released Forecast Spread | 13 823 13 887 -0.46% | 14 112 14 152 -0.28% | 15 416 15 540 -0.8% | 16 588 16 712 -0.74% | 16 665 16 417 1.51% | 16 634 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13 835 15 142 -8.63% | 8 940 9 963 -10.27% | 9 878 10 184 -3% | 26 137 18 886 38.39% | 8 371 10 562 -20.74% | 10 505 |
|
Net income Million USD | Released Forecast Spread | 12 611 13 384 -5.77% | 7 147 8 481 -15.73% | 8 072 8 392 -3.81% | 24 021 23 336 2.93% | 6 955 8 563 -18.78% | 9 817 |
|
EPS USD | Released Forecast Spread | 5,44 5,76 -5.5% | 3,12 3,88 -19.63% | 3,55 3,68 -3.52% | 10,7 10,3 3.79% | 3,19 4,06 -21.46% | 5,15 |
| Announcement Date | 01/30/19 | 01/29/20 | 01/26/21 | 02/02/22 | 02/01/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 030 13 016 0.11% | 13 229 13 251 -0.16% | 12 531 12 640 -0.86% | 12 781 12 739 0.33% | 12 543 12 737 -1.52% | 12 690 13 138 -3.41% | 12 953 12 567 3.07% | 13 622 13 270 2.65% | 11 782 11 373 3.6% | 11 719 | 12 623 | 13 263 | 13 487 | 13 533 |
|
EBITDA Million USD | Released Forecast Spread | 4 871 4 602 5.84% | 4 274 | 4 407 4 039 9.12% | 4 989 | 4 783 3 239 47.69% | 4 473 4 104 8.99% | 4 668 | |||||||
|
EBIT Million USD | Released Forecast Spread | 4 467 4 274 4.51% | 3 819 3 883 -1.65% | 4 083 4 092 -0.23% | 4 270 4 159 2.67% | 4 282 4 237 1.06% | 4 030 3 741 7.71% | 4 413 4 078 8.22% | 4 668 4 446 5% | 4 405 4 339 1.52% | 4 038 | 4 245 | 4 430 | 4 565 | 4 303 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 230 3 198 1% | 16 951 16 877 0.44% | 2 669 2 838 -5.95% | 2 042 2 548 -19.86% | 1 919 2 619 -26.73% | 1 741 2 521 -30.94% | 2 740 2 797 -2.04% | 2 769 3 194 -13.31% | 1 552 3 240 -52.1% | 3 443 | ||||
|
Net income Million USD | Released Forecast Spread | 2 758 2 858 -3.49% | 16 308 16 187 0.74% | 2 222 2 313 -3.93% | 1 695 2 340 -27.56% | 1 575 2 379 -33.79% | 1 466 2 919 -49.78% | 2 293 2 268 1.1% | 2 316 2 596 -10.8% | 1 513 2 786 -45.69% | 4 999 | ||||
|
EPS USD | Released Forecast Spread | 1,23 1,34 -8.51% | 7,29 7,19 1.4% | 1,00 1,04 -3.41% | 0,77 1,05 -26.4% | 0,73 1,17 -37.81% | 0,69 1,35 -48.9% | 1,09 1,07 1.82% | 1,11 1,26 -11.75% | 0,73 1,34 -45.68% | 1,56 | ||||
| Announcement Date | 10/26/21 | 02/02/22 | 04/26/22 | 07/19/22 | 10/25/22 | 02/01/23 | 04/25/23 | 07/18/23 | 10/24/23 | - | - | - | - | - |
| 2024-01-07 | Q2 2024 Earnings Release (Projected) |
| 2024-01-10 | Q3 2023 Earnings Release |
| 2024-01-22 | Q3 2024 Earnings Release (Projected) |
| 2024-01-23 06:20 am | Q4 2023 Earnings Release |
| 2024-01-24 | Q3 2023 Earnings Release (Projected) |
| 2024-01-25 | Q4 2023 Earnings Release (Projected) |
| 2024-01-25 | Q3 2024 Earnings Release (Projected) |
| 2024-01-28 | Q3 2024 Earnings Release (Projected) |
| 2024-01-28 | Q3 2023 Earnings Release (Projected) |
| 2024-01-29 | Q4 2023 Earnings Release (Projected) |
Past sector events for Novartis AG
| 2023-11-29 | Q3 2023 Earnings Release |
| 2023-11-27 | Q2 2024 Earnings Release |
| 2023-11-16 01:37 am | Q3 2023 Earnings Release |
| 2023-11-15 07:30 am | Q3 2023 Earnings Release |
| 2023-11-15 06:59 am | Q1 2024 Earnings Release |
| 2023-11-15 01:30 am | Q3 2023 Earnings Release |
| 2023-11-15 01:30 am | Q3 2023 Earnings Release |
| 2023-11-14 03:44 am | Q2 2024 Earnings Release |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-11-13 07:00 am | Q2 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Novartis AG - Swiss Exchange
- Calendar Novartis AG
